Stock SMSLIFE SMS LIFESCIENCES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company SMS Lifesciences India Limited

Equities

SMSLIFE

INE320X01016

Pharmaceuticals

End-of-day quote NSE India S.E.
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
801.8 INR -0.34% Intraday chart for SMS Lifesciences India Limited +6.03% +51.40%
27/05 SMS Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
10/02 SMS Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Business Summary

SMS Lifesciences India Limited is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph.Eur / IP, Famotidine USP / Ph.Eur / IP, Sildenafil Citrate USP / Ph.Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph.Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private limited.

Number of employees: 567

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
3,497 100.0 % 3,156 100.0 % -9.77%

Sales per region

INR in Million2022Weight2023Weight Delta
India
66.9 %
2,156 61.6 % 2,110 66.9 % -2.15%
International
32.8 %
1,317 37.7 % 1,037 32.8 % -21.30%
Global
0.3 %
24 0.7 % 9 0.3 % -61.16%

Managers

Managers TitleAgeSince
Talluri Veera V S N Murthy CEO
 Chief Executive Officer 64 01/16/01
N. Rajendra Prasad DFI
 Director of Finance/CFO - 01/17/01
Trupti Ranjan Mohanty CMP
 Compliance Officer - 14/20/14
Venkata Praveen Talluri BRD
 Director/Board Member - 01/17/01

Members of the board

Members of the board TitleAgeSince
Venkata Praveen Talluri BRD
 Director/Board Member - 01/17/01
Talluri Veera V S N Murthy CEO
 Chief Executive Officer 64 01/16/01
Sarath Kumar Pakalapati BRD
 Director/Board Member 67 25/17/25
Sudeepthi Gopineedi BRD
 Director/Board Member - 02/21/02
Mannam Malakondaiah BRD
 Director/Board Member 65 13/21/13
Srinivas Samavedam BRD
 Director/Board Member - 13/21/13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,023,287 791,169 ( 26.17 %) 0 26.17 %

Company contact information

SMS Lifesciences India Ltd.

Plot No. 19-III, Road No. 71 Opp. Bharatiya Vidya Bhavan Pub. Sch

500096, Hyderabad

+91 40 6628 8888

http://www.smslife.in
address SMS Lifesciences India Limited(SMSLIFE)

Group companies

NameCategory and Sector
Mahi Drugs Pvt Ltd.
Logo Mahi Drugs Pvt Ltd.

Mahi Drugs Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Mahi Drugs Pvt Ltd. manufactures active pharmaceutical ingredients. The company was founded on December 17, 2012 and is headquartered in Pharma, India.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SMS LIFESCIENCES INDIA LIMITED Stock SMS Lifesciences India Limited
+51.40% 29.02M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SMSLIFE Stock
  4. Company SMS Lifesciences India Limited